Douglas Richesson

1.6k total citations
15 papers, 796 citations indexed

About

Douglas Richesson is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, Douglas Richesson has authored 15 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 6 papers in Genetics. Recurrent topics in Douglas Richesson's work include Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Estrogen and related hormone effects (3 papers). Douglas Richesson is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Ovarian cancer diagnosis and treatment (4 papers) and Estrogen and related hormone effects (3 papers). Douglas Richesson collaborates with scholars based in United States, Poland and Germany. Douglas Richesson's co-authors include James V. Lacey, Brenda B. Rush, Andrew G. Glass, Nilanjan Chatterjee, Brigitte M. Ronnett, Olga B. Ioffe, Bryan Langholz, Arthur Schatzkin, Louise A. Brinton and Gretchen L. Gierach and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Douglas Richesson

15 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas Richesson United States	12	336	273	248	165	149	15	796
Roland Matthews United States	17	179 0.5×	156 0.6×	83 0.3×	162 1.0×	269 1.8×	42	732
Megan McDonald United States	17	232 0.7×	208 0.8×	179 0.7×	186 1.1×	353 2.4×	59	879
Ann‐Cathrin Hellström Sweden	18	227 0.7×	138 0.5×	133 0.5×	160 1.0×	175 1.2×	31	700
Kathryn A. Maurer United States	12	252 0.8×	169 0.6×	63 0.3×	119 0.7×	120 0.8×	24	548
Yoo‐Kyung Lee South Korea	16	213 0.6×	217 0.8×	45 0.2×	163 1.0×	178 1.2×	32	707
D. Stirling United Kingdom	14	38 0.1×	219 0.8×	337 1.4×	103 0.6×	206 1.4×	26	889
Ilan Cohen Israel	20	685 2.0×	531 1.9×	466 1.9×	132 0.8×	69 0.5×	48	1.1k
Ismael D.C.G. Silva Brazil	11	74 0.2×	97 0.4×	71 0.3×	153 0.9×	171 1.1×	17	533
Francesco Battaglia Italy	11	184 0.5×	122 0.4×	64 0.3×	73 0.4×	120 0.8×	18	470

Countries citing papers authored by Douglas Richesson

Since Specialization

Citations

This map shows the geographic impact of Douglas Richesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Richesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Richesson more than expected).

Fields of papers citing papers by Douglas Richesson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Richesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Richesson. The network helps show where Douglas Richesson may publish in the future.

Co-authorship network of co-authors of Douglas Richesson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Richesson. A scholar is included among the top collaborators of Douglas Richesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Richesson. Douglas Richesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Clifford, Robert, Uzo Chukwuma, Michael E. Sparks, et al.. (2018). Semi-Automated Visualization and ANalysis of Trends: A “SAVANT” for Facilitating Antimicrobial Stewardship Using Antistaphylococcal Resistance and Consumption as a Prototype. Open Forum Infectious Diseases. 5(4). ofy066–ofy066. 1 indexed citations

Clifford, Robert, Michael E. Sparks, Ana Ong, et al.. (2016). Correlating Cleaning Thoroughness with Effectiveness and Briefly Intervening to Affect Cleaning Outcomes: How Clean Is Cleaned?. PLoS ONE. 11(5). e0155779–e0155779. 7 indexed citations

Lesho, Emil, Uzo Chukwuma, Michael E. Sparks, et al.. (2016). Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of Defense. Journal of Clinical Microbiology. 54(6). 1546–1551. 9 indexed citations

Lacey, James V., Victoria M. Chia, Brenda B. Rush, et al.. (2012). Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. International Journal of Cancer. 131(8). 1921–1929. 31 indexed citations

Lacey, James V., Mark E. Sherman, Brenda B. Rush, et al.. (2010). Absolute Risk of Endometrial Carcinoma During 20-Year Follow-Up Among Women With Endometrial Hyperplasia. Journal of Clinical Oncology. 28(5). 788–792. 182 indexed citations

Morton, Lindsay M., Sophia Wang, Douglas Richesson, et al.. (2008). Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health‐AARP Diet and Health Study Cohort. International Journal of Cancer. 124(11). 2737–2743. 31 indexed citations

Lacey, James V., George L. Mutter, Marisa R. Nucci, et al.. (2008). Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer. 113(8). 2073–2081. 52 indexed citations

Sherman, Mark E., Brigitte M. Ronnett, Olga B. Ioffe, et al.. (2008). Reproducibility of Biopsy Diagnoses of Endometrial Hyperplasia: Evidence Supporting a Simplified Classification. International Journal of Gynecological Pathology. 27(3). 318–325. 27 indexed citations

Brinton, Louise A., Douglas Richesson, Gretchen L. Gierach, et al.. (2008). Prospective Evaluation of Risk Factors for Male Breast Cancer. JNCI Journal of the National Cancer Institute. 100(20). 1477–1481. 101 indexed citations

10.

Gierach, Gretchen L., James V. Lacey, Arthur Schatzkin, et al.. (2008). Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study. Breast Cancer Research. 10(2). R38–R38. 71 indexed citations

11.

Brinton, Louise A., Douglas Richesson, Michael F. Leitzmann, et al.. (2008). Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiology Biomarkers & Prevention. 17(11). 3150–3160. 55 indexed citations

12.

Lacey, James V., George L. Mutter, Brigitte M. Ronnett, et al.. (2008). PTEN Expression in Endometrial Biopsies as a Marker of Progression to Endometrial Carcinoma. Cancer Research. 68(14). 6014–6020. 58 indexed citations

13.

García‐Closas, Montserrat, Louise A. Brinton, Jolanta Lissowska, et al.. (2007). Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer. 7(1). 60–60. 23 indexed citations

14.

Savage, Sharon A., Stephen J. Chanock, Jolanta Lissowska, et al.. (2007). Genetic variation in five genes important in telomere biology and risk for breast cancer. British Journal of Cancer. 97(6). 832–836. 66 indexed citations

15.

Lacey, J., Olga B. Ioffe, Brigitte M. Ronnett, et al.. (2007). Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. British Journal of Cancer. 98(1). 45–53. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact